NOVABAY PHARMACEUTICALS INC (NBY)
US66987P4090 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.42M -15.21% | 14.4M 71.02% | 14.726M 2.26% | 10.898M -25.99% | 13.736M 26.04% | 16.004M 16.51% | |
| EBITDA YoY % growth | -6.74M -5.64% | -7.2M -6.82% | -4.8M 33.33% | -4.949M -3.10% | -2.626M 46.94% | N/A | |
| EBIT YoY % growth | -6.86M -6.69% | -7.68M -11.95% | -5.003M 34.86% | -5.388M -7.70% | -3.894M 27.74% | -2.586M 33.59% | |
| Operating Margin | -81.47% | -53.33% | -33.97% | -49.44% | -28.35% | -16.16% | |
| EPS YoY % growth | -183.75 54.55% | -260.05 -41.52% | -111.65 57.07% | -1.42 98.72% | -0.85 40.07% | -0.38 55.03% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 99.76% | -0.31 94.13% | -0.21 84.52% | -0.22 34.20% | -0.12 -9.09% | -0.20 34.43% | -0.11 47.62% | -0.12 44.19% | 0.03 125.00% |
| Revenue Q2Q % growth | 3.184M -14.57% | 3.03M 15.17% | 2.897M 20.71% | 3.096M 26.83% | 3.705M 16.36% | 3.636M 20.00% | 3.317M 14.50% | 3.796M 22.61% | 5.256M 41.86% |
| EBITDA Q2Q % growth | -707K -18.82% | -808K 48.17% | -606K 41.17% | -606K 41.11% | -606K 14.29% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -757.5K 5.08% | -1.298M 17.39% | -984.75K 6.48% | -1.05M 1.00% | -606K 20.00% | -1.232M 5.06% | -727.2K 26.15% | -838.3K 20.19% | 212.1K 135.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.33 97.45% | -0.31 | -0.02 | -7.13% |
| Q2 2024 Q2Q % growth | -1.37 93.88% | -1.24 | -0.13 | -10.73% |
| Q1 2024 Q2Q % growth | -5.25 82.35% | -5.30 | 0.05 | 0.99% |
| Q4 2023 Q2Q % growth | -46.55 -70.51% | -10.61 | -35.94 | -338.94% |
| Q3 2023 Q2Q % growth | -12.95 89.43% | -14.26 | 1.31 | 9.21% |
| Q2 2023 Q2Q % growth | -22.40 54.29% | -19.62 | -2.78 | -14.17% |
| Q1 2023 Q2Q % growth | -29.75 51.43% | -32.17 | 2.42 | 7.52% |
| Q4 2022 Q2Q % growth | -27.30 -11.43% | -6.01 | -21.29 | -354.28% |
| Q3 2022 Q2Q % growth | -122.50 -100.00% | -43.30 | -79.20 | -182.89% |
| Q2 2022 Q2Q % growth | -49.00 | -43.30 | -5.70 | -13.15% |
| Q1 2022 Q2Q % growth | -61.25 -25.00% | -37.12 | -24.13 | -65.02% |
| Q4 2021 Q2Q % growth | -24.50 50.00% | -61.86 | 37.36 | 60.40% |
| Q3 2021 Q2Q % growth | -61.25 37.50% | -49.49 | -11.76 | -23.76% |
| Q2 2021 Q2Q % growth | -49.00 73.33% | -49.49 | 0.49 | 0.99% |
| Q1 2021 Q2Q % growth | -49.00 33.33% | -49.49 | 0.49 | 0.99% |
| Q4 2020 Q2Q % growth | -49.00 69.23% | -55.68 | 6.68 | 11.99% |
| Q3 2020 Q2Q % growth | -98.00 -700.00% | -49.49 | -48.51 | -98.02% |
| Q2 2020 Q2Q % growth | -183.75 -66.67% | -68.05 | -115.70 | -170.03% |
| Q1 2020 Q2Q % growth | -73.50 76.00% | -86.61 | 13.11 | 15.13% |
| Q4 2019 Q2Q % growth | -159.25 -85.71% | -86.61 | -72.64 | -83.88% |
| Q3 2019 Q2Q % growth | -12.25 88.89% | -98.98 | 86.73 | 87.62% |
| Q2 2019 Q2Q % growth | -110.25 | -86.61 | -23.64 | -27.30% |
| Q1 2019 Q2Q % growth | -306.25 -92.31% | -142.28 | -163.97 | -115.24% |
| Q4 2018 Q2Q % growth | -85.75 | -103.10 | 17.35 | 16.83% |
| Q3 2018 Q2Q % growth | -110.25 | -139.19 | 28.94 | 20.79% |
| Q2 2018 Q2Q % growth | -110.25 | -148.47 | 38.22 | 25.74% |
| Q1 2018 Q2Q % growth | -159.25 | -92.79 | -66.46 | -71.62% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.441M -25.24% | 2.649M | -208K | -7.85% |
| Q2 2024 Q2Q % growth | 2.4M -47.94% | 3.186M | -786K | -24.67% |
| Q1 2024 Q2Q % growth | 2.631M -15.78% | 3.314M | -683K | -20.61% |
| Q4 2023 Q2Q % growth | 3.727M 2.39% | 3.434M | 293K | 8.53% |
| Q3 2023 Q2Q % growth | 3.265M -14.75% | 3.582M | -317K | -8.85% |
| Q2 2023 Q2Q % growth | 4.61M 25.96% | 3.712M | 898K | 24.19% |
| Q1 2023 Q2Q % growth | 3.124M -4.46% | 3.232M | -108K | -3.34% |
| Q4 2022 Q2Q % growth | 3.64M 37.88% | 5.151M | -1.511M | -29.33% |
| Q3 2022 Q2Q % growth | 3.83M 68.72% | 3.788M | 42K | 1.11% |
| Q2 2022 Q2Q % growth | 3.66M 23.65% | 3.545M | 115K | 3.24% |
| Q1 2022 Q2Q % growth | 3.27M 80.66% | 3.293M | -23K | -0.70% |
| Q4 2021 Q2Q % growth | 2.64M 39.68% | 3.378M | -738K | -21.85% |
| Q3 2021 Q2Q % growth | 2.27M 4.61% | 2.459M | -189K | -7.69% |
| Q2 2021 Q2Q % growth | 2.96M -25.63% | 2.02M | 940K | 46.53% |
| Q1 2021 Q2Q % growth | 1.81M -4.23% | 2.363M | -553K | -23.40% |
| Q4 2020 Q2Q % growth | 1.89M 11.18% | 2.505M | -615K | -24.55% |
| Q3 2020 Q2Q % growth | 2.17M 33.95% | 2.55M | -380K | -14.90% |
| Q2 2020 Q2Q % growth | 3.98M 122.35% | 2.879M | 1.101M | 38.24% |
| Q1 2020 Q2Q % growth | 1.89M 26.85% | 2.116M | -226K | -10.68% |
| Q4 2019 Q2Q % growth | 1.7M -53.17% | 2.091M | -391K | -18.70% |
| Q3 2019 Q2Q % growth | 1.62M -48.41% | 2.065M | -445K | -21.55% |
| Q2 2019 Q2Q % growth | 1.79M -35.84% | 1.667M | 123K | 7.38% |
| Q1 2019 Q2Q % growth | 1.49M -49.49% | 2.108M | -618K | -29.32% |
| Q4 2018 Q2Q % growth | 3.63M | 3.784M | -154K | -4.07% |
| Q3 2018 Q2Q % growth | 3.14M | 3.866M | -726K | -18.78% |
| Q2 2018 Q2Q % growth | 2.79M | 3.626M | -836K | -23.06% |
| Q1 2018 Q2Q % growth | 2.95M | 4.633M | -1.683M | -36.33% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -29.41% | -29.41% | 0% | 58.65% |
| Revenue | -29.51% | -29.51% | 0% | -10.75% |